NEW YORK (GenomeWeb) – Synthetic biology company Ginkgo Bioworks and robotic automation software developer Transcriptic have been awarded a joint $9.5 million contract from the Defense Advanced Research Projects Agency (DARPA) through its Synergistic Discovery and Design Program (SD2).

Ginkgo and Transcriptic said they will use the SD2 funds to incorporate machine learning, closed loop biology, and automated execution of protocols to advance biological experimentation and accelerate iterative testing for synthetic biology.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Direct-to-consumer genetic testing companies have offered to test families separated at the southern US border, but that raises ethical issues.

CNBC reports that confirming a positive result from 23andMe's BRCA health report can be expensive.

The New York Times reports on a project to develop a tree DNA database to uncover illegal logging.

In PLOS this week: links between gut microbiome and colorectal cancer mutations, targeted sequencing uncovers genetic susceptibilities to epilepsy in Koreans, and more.